Document is current
Any future updates will be listed below
-
Authors
Christofides, Anthos
Strauss, Laura
Yeo, Alan
Cao, Carol
Charest, Alain https://orcid.org/0000-0002-1548-6950
Boussiotis, Vassiliki A. https://orcid.org/0000-0002-3963-1518
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA238263, CA229784, CA229784)
- License Information
-
More Information
Article History
Received: 19 January 2022
Accepted: 10 June 2022
First Online: 25 July 2022
Competing interests
: V.A.B. has patents on the PD-1 pathway licensed by Bristol-Myers Squibb, Roche, Merck, EMD-Serono, Boehringer Ingelheim, AstraZeneca, Novartis, and Dako. The authors declare no other competing interests.
